PDLI has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Cash flow for capital expenditures refers to the cash generated minus spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.
PDL BioPharma Inc's cash flow for capital expenditures for the three months ended in Mar. 2016 was $0.0 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2016 was $0.0 Mil.
PDL BioPharma Inc Cash Flow for Capital Expenditures for the trailing twelve months (TTM) ended in Mar. 2016 was 0 (Jun. 2015 ) + 0 (Sep. 2015 ) + 0 (Dec. 2015 ) + 0 (Mar. 2016 ) = $0.0 Mil.
PDL BioPharma Inc Annual Data
PDL BioPharma Inc Quarterly Data